Remove topics milestone-payments
article thumbnail

Training AI models on Synthetic Data: No silver bullet for IP infringement risk in the context of training AI systems (Part 3 of 4)

LexBlog IP

14] Coming up in this Series In the fourth and final part of this Series, we will explore certain other key legal topics to be considered when using synthetic data to train an AI model and summarize our conclusions. [1] 1] Directive (EU) 2019/790 of 17 April 2019 on copyright and related rights in the Digital Single Market, OJ 130/92, pp.

IP 52
article thumbnail

Biosimilars 2021 Year in Review

Fish & Richardson Trademark & Copyright Thoughts

2021 saw several important milestones in the biosimilars space, including the much anticipated first interchangeable designations by FDA and the approval of the first ophthalmology biosimilar. Introduction. Yet, given fewer FDA approvals in 2020 and 2021, this year saw the lowest number of commercial launches since 2017.